GlassScriptPhysician profile
Quang H Pham
NPI 1376957589
$1,917.14
in general payments reported to CMS, 2019-2025
13 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2021: $1,218 · 2023: $61.03 · 2024: $128 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.42 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,130.92 | 2021 | |
| Smith+Nephew, INC. | $169.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2024 | |
| Neurent Medical Limited | $87.08 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Intersect Ent, INC. | $72.97 | 2021 | |
| Glaxosmithkline, LLC. | $72.60 | 2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $63.52 | 2025 | Dupixent |
| Aerin Medical INC. | $58.40 | 2023-2025 | |
| Ambu INC. | $58.18 | 2023-2024 | |
| Cochlear Americas | $44.22 | 2019-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Genzyme Corporation | $27.97 | 2025 | |
| Inspire Medical Systems, INC. | $17.70 | 2025 | Inspire |
| Optinose US, INC. | $14.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quang Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.